
These disruptions force stakeholders to address critical strategic questions :


How to pivot GenAI from "pilot" to a core driver of ROI and customeracquisition ?
How to ensure DORA compliance and security in an open, fragmented ecosystem ?


How to redefine the portfolio: compete as a distributor or partner as a "manufacturing" utility ?



